These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 27693409)

  • 1. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
    AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
    Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
    Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
    Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum paraoxonase level and paraoxonase polymorphism in patients with acromegaly.
    Arpaci D; Karakas Celik S; Can M; Ermiş E; Kuzu F; Kokturk F; Hamamcioglu AC; Dursun A; Bayraktaroglu T
    Redox Rep; 2016 Nov; 21(6):281-6. PubMed ID: 26863932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
    Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
    Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
    Sampson MJ; Braschi S; Willis G; Astley SB
    Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase (PON1) polymorphism & its relation with lipids in north west Indian Punjabis.
    Singh S; Verma M; Nain CK; Leelamma CO; Goel RC
    Indian J Med Res; 1999 Oct; 110():133-7. PubMed ID: 10645101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular distribution of antioxidant enzyme paraoxonase & its alteration in cataractous lens & diabetic retina.
    Bharathidevi SR; Babu KA; Jain N; Muthukumaran S; Umashankar V; Biswas J; Angayarkanni N
    Indian J Med Res; 2017 Apr; 145(4):513-520. PubMed ID: 28862184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Paraoxonase-1 and Butyrylcholinesterase Activities and Nutritional Status in Mexican Children.
    Ramírez-Jiménez R; Martínez-Salazar MF; Almenares-López D; Yáñez-Estrada L; Monroy-Noyola A
    Metab Syndr Relat Disord; 2018 Mar; 16(2):90-96. PubMed ID: 29393817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients.
    Zaragoza-García O; Guzmán-Guzmán IP; Moreno-Godínez ME; Navarro-Zarza JE; Antonio-Vejar V; Ramírez M; Parra-Rojas I
    Clin Rheumatol; 2021 Feb; 40(2):741-752. PubMed ID: 32556934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
    Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum PON-1 activity but not Q192R polymorphism is related to the extent of atherosclerosis.
    Bayrak A; Bayrak T; Tokgözoglu SL; Volkan-Salanci B; Deniz A; Yavuz B; Alikasifoglu M; Demirpençe E
    J Atheroscler Thromb; 2012; 19(4):376-84. PubMed ID: 22188760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum paraoxonase 1 activity and increased serum homocysteine and malondialdehyde levels in age-related macular degeneration.
    Ates O; Azizi S; Alp HH; Kiziltunc A; Beydemir S; Cinici E; Kocer I; Baykal O
    Tohoku J Exp Med; 2009 Jan; 217(1):17-22. PubMed ID: 19155603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Variants and Systemic Complement Activation Levels Are Associated With Serum Lipoprotein Levels in Age-Related Macular Degeneration.
    Paun CC; Ersoy L; Schick T; Groenewoud JM; Lechanteur YT; Fauser S; Hoyng CB; de Jong EK; den Hollander AI
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7766-73. PubMed ID: 26641553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes.
    Zargari M; Sharafeddin F; Mahrooz A; Alizadeh A; Masoumi P
    Exp Biol Med (Maywood); 2016 Aug; 241(14):1489-96. PubMed ID: 27022137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder.
    Bortolasci CC; Vargas HO; Souza-Nogueira A; Barbosa DS; Moreira EG; Nunes SO; Berk M; Dodd S; Maes M
    J Affect Disord; 2014 Apr; 159():23-30. PubMed ID: 24679385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
    Agachan B; Yilmaz H; Karaali Z; Isbir T
    Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.